Skip to main content

Megna Michael R

Chief Accounting Officer | Chief Accounting Officer

1 company

Insider Signal Score

44
Weak
Trades Analyzed
12
12M Win Rate
22.2%
Avg 3M Return
-5.9%
Avg 12M Return
-50.2%

Megna Michael R is a Chief Accounting Officer at Kiniksa Pharmaceuticals International, plc. Recent SEC Form 4 filings include 0 buys and 13 sells.

Estimated insider holdings value: $3.0M based on current market prices.

Holdings by Company

KNSAOct 20, 2025
Current Shares38.9K
Value$3.04M
Net Activity-169,816
Bought: 0Sold: 169.8K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Oct 20, 2025
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE50,490$38.87$1,962,781.45-42.9%+5.2%-
Sep 3, 2025
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE11,000$34.84$383,240.00-22.4%+12.9%-
Aug 4, 2025
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE17,000$32.35$549,950.00-34.0%+13.7%+125.6%
Jun 3, 2025
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE15,211$28.75$437,316.25-31.9%+17.8%+66.4%
May 7, 2025
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE17,647$26.69$470,998.43-35.2%+23.5%+112.7%
Mar 12, 2025
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE9,051$22.45$203,194.95-25.4%+32.3%+104.8%
Nov 29, 2024
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE8,646$22.45$194,102.70-14.0%-11.1%+92.6%
Mar 1, 2024
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE14,785$21.57$318,881.09-29.6%-14.6%-6.7%
Jan 2, 2024
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE16,670$19.17$319,563.90-49.5%+6.3%+7.6%
Dec 19, 2023
KNSA
Kiniksa Pharmaceuticals International, Plc
Chief Accounting OfficerSale+OE9,316$19.13$178,215.08-35.4%+2.7%+5.2%